Stay updated on Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page.

Latest updates to the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page
- Check4 days agoChange DetectedLatest history entry shows Revision: v3.3.3 added; HHS Vulnerability Disclosure and Revision: v3.3.2 removed from the footer.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe version history shows internal revision updates with v3.3.2 added and v3.2.0 removed, which do not affect trial data or public content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedThe site-wide government funding/operating status notice has been removed from the page header. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check54 days agoChange DetectedOn 2025-10-29, the record was updated to include a Results Posted entry, adding the Results, Outcome Measures, and Study Status details. The 2025-07-08 entry for 'Results Submitted' was removed, and the 2025-10-15 version 36 consolidates these updates.SummaryDifference0.5%

- Check82 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference10%

- Check89 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.2%

Stay in the know with updates to Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page.